Table 3 of Teper, Mol Vis 2010; 16:2598-2604.
Dependent | BCVA change (final BCVA – BCVA at baseline) | CSRT change (CSRT at baseline – final CSRT) | Number of injections | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Coefficient of determination R2 | 0.2004 | 0.5718 | 0.1122 | |||||||||
R2-adjusted | 0.1215 | 0.5295 | 0.02454 | |||||||||
Multiple correlation coefficient | 0.4477 | 0.7562 | 0.335 | |||||||||
Residual standard deviation | 7.6097 | 64.9625 | 1.4957 | |||||||||
Regression equation | Coefficient | Std. Error | t | p | Coefficient | Std. Error | t | p | Coefficient | Std. Error | t | p |
69S | −2.655 | 1.0654 | −2.492 | 0.0147 | 9.486 | 9.0955 | 1.043 | 0.3001 | 0.1863 | 0.2094 | 0.89 | 0.3763 |
402H | −1.7727 | 1.2004 | −1.477 | 0.1436 | −10.0345 | 10.2473 | −0.979 | 0.3304 | 0.325 | 0.2359 | 1.377 | 0.1722 |
CNV type | −1.4099 | 1.0405 | −1.355 | 0.1792 | −12.274 | 8.8828 | −1.382 | 0.1708 | 0.2841 | 0.2045 | 1.389 | 0.1687 |
Lesion area at baseline | −0.114 | 0.07928 | −1.439 | 0.1541 | −1.2062 | 0.6768 | −1.782 | 0.0784 | 0.01053 | 0.01558 | 0.676 | 0.5012 |
CSRT at baseline | 0.01698 | 0.008583 | 1.978 | 0.0513 | 0.7378 | 0.07327 | 10.07 | <0.0001 | 0.003203 | 0.001687 | 1.899 | 0.0611 |
BCVA at baseline | −0.01153 | 0.05763 | −0.2 | 0.8419 | −0.4074 | 0.492 | −0.828 | 0.41 | 0.005864 | 0.01133 | 0.518 | 0.6061 |
Age | −0.1456 | 0.09868 | −1.475 | 0.1441 | 0.7436 | 0.8425 | 0.883 | 0.38 | 0.006667 | 0.0194 | 0.344 | 0.7319 |
Gender | −0.6197 | 1.6361 | −0.379 | 0.7059 | 9.5343 | 13.9674 | 0.683 | 0.4968 | 0.1664 | 0.3216 | 0.517 | 0.6063 |
Analysis of variance | DF | Sum of Squares | Mean Square | DF | Sum of Squares | Mean Square | DF | Sum of Squares | Mean Square | |||
Regression | 8 | 1175.763 | 146.9703 | 8 | 456406.7 | 57050.84 | 8 | 22.9046 | 2.8631 | |||
Residual | 81 | 4690.46 | 57.9069 | 81 | 341830.2 | 4220.126 | 81 | 181.1954 | 2.237 | |||
F-ratio | 2.538 | 13.51875 | 1.2799 | |||||||||
Significance level | p=0.016 | p<0.001 | p=0.266 |